Fund Details
Aditya Birla Sun Life Resurgent India Fund Series 7 Regular Dividend
| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.31% |
| NAV | ₹8.53 (27 Jan 2021) |
|---|---|
| Fund Started | 06 Apr 2018 |
| Fund Size | ₹105 Cr |
Returns
Comparison
Found nothing so far.
Found nothing so far.
Top Holdings
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Bandhan Bank Ltd. | Financial | Equity | 8.0% |
| Bharat Petroleum Corpn. Ltd. | Energy | Equity | 7.4% |
| Mahindra & Mahindra Financial Services Ltd. | Financial | Equity | 6.8% |
| Strides Pharma Science Ltd. | Healthcare | Equity | 4.2% |
| Biocon Ltd. | Healthcare | Equity | 4.1% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.0% |
| Century Textiles & Inds. Ltd. | Diversified | Equity | 3.9% |
| Tata Consumer Products Ltd. | FMCG | Equity | 3.8% |
| Escorts Ltd. | Automobile | Equity | 3.7% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 3.5% |
Fund Managers
Aditya Birla Sun Life Resurgent India Fund Series 7 Regular Dividend Details
Aditya Birla Sun Life Resurgent India Fund Series 7 Regular Dividend is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was made available to investors on 06 Apr 2018. Satyabrata Mohanty, Milind Bafna is the Current Fund Manager of Aditya Birla Sun Life Resurgent India Fund Series 7 Regular Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹105 Cr and the Latest NAV as of 27 Jan 2021 is ₹8.53.
The Aditya Birla Sun Life Resurgent India Fund Series 7 Regular Dividend is rated Moderately High risk.
Investment Objective
The scheme seeks to provide capital appreciation by investing primarily in equity and equity related securities that are likely to benefit from recovery in the Indian economy.
